• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于(1,10-菲咯啉-2-基)异恶唑烷-5-基核心的DNA嵌入剂,对头颈部鳞状细胞癌具有比顺铂更好的生长抑制作用和选择性。

DNA intercalators based on (1,10-phenanthrolin-2-yl)isoxazolidin-5-yl core with better growth inhibition and selectivity than cisplatin upon head and neck squamous cells carcinoma.

作者信息

Varrica Maria G, Zagni Chiara, Mineo Placido G, Floresta Giuseppe, Monciino Giulia, Pistarà Venerando, Abbadessa Antonio, Nicosia Angelo, Castilho Rogerio M, Amata Emanuele, Rescifina Antonio

机构信息

Dipartimento di Scienze del Farmaco, Università degli Studi di Catania, V.le A. Doria, 95125, Catania, Italy.

Dipartimento di Scienze Chimiche, Università di Catania, Viale A. Doria, 6, 95125, Catania, Italy; CNR-IPCB Istituto per i Polimeri, Compositi e Biomateriali, Via P. Gaifami 18, I-95126, Catania, Italy; CNR-IPCF Istituto per i Processi Chimico-Fisici, Viale F. Stagno d'Alcontres 37, I-98158, Messina, Italy; INSTM Consorzio Interuniversitario Nazionale per la Scienza e Tecnologia dei Materiali (UdR of Catania), Viale A. Doria, 6, I-95125, Catania, Italy.

出版信息

Eur J Med Chem. 2018 Jan 1;143:583-590. doi: 10.1016/j.ejmech.2017.11.067. Epub 2017 Nov 26.

DOI:10.1016/j.ejmech.2017.11.067
PMID:29207341
Abstract

((3RS,5SR)- and ((3RS,5RS)-2-(2-methoxybenzyl)-3-(1,10-phenanthrolin-2-yl)isoxazolidin-5-yl)methanol have been synthesized, according to 1,3-dipolar cycloaddition methodology, as DNA intercalating agents and evaluated for their anticancer activity against human cervical carcinoma HeLa and head and neck squamous cells carcinoma cell lines. The synthesized compounds exhibited good cytotoxic activity with IC better than cisplatin, used as the main and effective treatment for HNSCC, and a 24.3-72.0-fold selectivity respect to the 184B5 non-cancerous immortalized breast epithelial cell lines. Unwinding assay, circular dichroism data, and Uv-vis melting experiments confirmed that these compounds act as DNA intercalators with a binding constant in the order of 10 M. Docking studies showed that both compounds can interact as intercalating agent with both poly-d(AT) and poly-d(GC), preferring an entrance by the minor groove of the poly-d(AT).

摘要

根据1,3 - 偶极环加成方法合成了((3RS,5SR)-和((3RS,5RS)-2-(2 - 甲氧基苄基)-3-(1,10 - 菲咯啉 - 2 - 基)异恶唑烷 - 5 - 基)甲醇,作为DNA嵌入剂,并评估了它们对人宫颈癌HeLa细胞和头颈部鳞状细胞癌细胞系的抗癌活性。合成的化合物表现出良好的细胞毒性活性,其IC优于顺铂(顺铂用作头颈部鳞状细胞癌的主要有效治疗药物),并且相对于184B5非癌永生化乳腺上皮细胞系具有24.3 - 72.0倍的选择性。解旋测定、圆二色性数据和紫外 - 可见熔解实验证实这些化合物作为DNA嵌入剂起作用,结合常数约为10 M。对接研究表明,这两种化合物都可以作为嵌入剂与聚 - d(AT)和聚 - d(GC)相互作用,更倾向于通过聚 - d(AT)的小沟进入。

相似文献

1
DNA intercalators based on (1,10-phenanthrolin-2-yl)isoxazolidin-5-yl core with better growth inhibition and selectivity than cisplatin upon head and neck squamous cells carcinoma.基于(1,10-菲咯啉-2-基)异恶唑烷-5-基核心的DNA嵌入剂,对头颈部鳞状细胞癌具有比顺铂更好的生长抑制作用和选择性。
Eur J Med Chem. 2018 Jan 1;143:583-590. doi: 10.1016/j.ejmech.2017.11.067. Epub 2017 Nov 26.
2
Novel isoxazole polycyclic aromatic hydrocarbons as DNA-intercalating agents.新型异恶唑稠环芳烃作为 DNA 嵌入剂。
Eur J Med Chem. 2012 May;51:163-73. doi: 10.1016/j.ejmech.2012.02.038. Epub 2012 Feb 25.
3
Development of peptide inhibitor as a therapeutic agent against head and neck squamous cell carcinoma (HNSCC) targeting p38alpha MAP kinase.靶向p38α丝裂原活化蛋白激酶的肽抑制剂作为治疗头颈部鳞状细胞癌(HNSCC)治疗剂的开发。
Biochim Biophys Acta. 2013 Mar;1830(3):2763-9. doi: 10.1016/j.bbagen.2012.12.001.
4
Synthesis and biological activity of isoxazolidinyl polycyclic aromatic hydrocarbons: potential DNA intercalators.异恶唑烷基亚多环芳烃的合成与生物活性:潜在的DNA嵌入剂
J Med Chem. 2006 Jan 26;49(2):709-15. doi: 10.1021/jm050772b.
5
Synthesis and biological activity of novel bifunctional isoxazolidinyl polycyclic aromatic hydrocarbons.新型双功能异噁唑烷并多环芳烃的合成及生物活性。
Bioorg Med Chem. 2012 Aug 15;20(16):4978-84. doi: 10.1016/j.bmc.2012.06.035. Epub 2012 Jun 26.
6
cRGD peptide installation on cisplatin-loaded nanomedicines enhances efficacy against locally advanced head and neck squamous cell carcinoma bearing cancer stem-like cells.载顺铂纳米药物上 cRGD 肽的安装增强了对具有癌症干细胞样细胞的局部晚期头颈部鳞状细胞癌的疗效。
J Control Release. 2017 Sep 10;261:275-286. doi: 10.1016/j.jconrel.2017.06.021. Epub 2017 Jun 27.
7
CCI-779 (Temsirolimus) exhibits increased anti-tumor activity in low EGFR expressing HNSCC cell lines and is effective in cells with acquired resistance to cisplatin or cetuximab.CCI-779(替西罗莫司)在低表皮生长因子受体(EGFR)表达的头颈部鳞状细胞癌(HNSCC)细胞系中显示出增强的抗肿瘤活性,并且对顺铂或西妥昔单抗获得性耐药的细胞有效。
J Transl Med. 2015 Apr 1;13:106. doi: 10.1186/s12967-015-0456-6.
8
Anthelmintic mebendazole enhances cisplatin's effect on suppressing cell proliferation and promotes differentiation of head and neck squamous cell carcinoma (HNSCC).抗蠕虫药甲苯达唑增强顺铂对抑制细胞增殖的作用,并促进头颈部鳞状细胞癌(HNSCC)的分化。
Oncotarget. 2017 Feb 21;8(8):12968-12982. doi: 10.18632/oncotarget.14673.
9
Serendipitous discovery of potent human head and neck squamous cell carcinoma anti-cancer molecules: A fortunate failure of a rational molecular design.偶然发现强效人头颈鳞状细胞癌抗癌分子:合理分子设计的一次幸运失败。
Eur J Med Chem. 2017 Dec 1;141:188-196. doi: 10.1016/j.ejmech.2017.09.075. Epub 2017 Oct 5.
10
Synthesis and cytotoxic activity evaluation of some novel 1-(3-(aryl-4,5-dihydroisoxazol-5-yl)methyl)-4-trihalomethyl-1H-pyrimidin-2-ones in human cancer cells.一些新型1-(3-(芳基-4,5-二氢异恶唑-5-基)甲基)-4-三卤甲基-1H-嘧啶-2-酮在人癌细胞中的合成及细胞毒性活性评估
Eur J Med Chem. 2015 Aug 28;101:836-42. doi: 10.1016/j.ejmech.2015.06.040. Epub 2015 Jun 24.

引用本文的文献

1
Xylazine as an emerging new psychoactive substance; focuses on both 5-HT and κ-opioid receptors' molecular interactions and isosteric replacement.赛拉嗪作为一种新兴的新型精神活性物质;聚焦于5-羟色胺和κ-阿片受体的分子相互作用及等排取代。
Arch Pharm (Weinheim). 2025 Mar;358(3):e2500041. doi: 10.1002/ardp.202500041.
2
Design, Synthesis, and Evaluation of Novel (-)-cis-N-Normetazocine Derivatives: In Vitro and Molecular Modeling Insights.新型(-)-顺式-N-去甲左啡诺衍生物的设计、合成与评价:体外及分子模拟研究
Chem Biol Drug Des. 2024 Dec;104(6):e70037. doi: 10.1111/cbdd.70037.
3
The Benzoxazole Heterocycle: A Comprehensive Review of the Most Recent Medicinal Chemistry Developments of Antiproliferative, Brain-Penetrant, and Anti-inflammatory Agents.
苯并恶唑杂环:抗增殖、穿透血脑屏障和抗炎药物的最新药物化学发展的综合综述。
Top Curr Chem (Cham). 2024 Oct 21;382(4):33. doi: 10.1007/s41061-024-00477-6.
4
Heparan Sulfate and Enoxaparin Interact at the Interface of the Spike Protein of HCoV-229E but Not with HCoV-OC43.硫酸乙酰肝素和依诺肝素在 HCoV-229E 刺突蛋白的界面相互作用,但不与 HCoV-OC43 相互作用。
Viruses. 2023 Mar 1;15(3):663. doi: 10.3390/v15030663.
5
Soluble peptidoglycan fragments produced by with antiproliferative activity are suitable for potential therapeutic development: A preliminary report.具有抗增殖活性的[具体产生主体未给出]产生的可溶性肽聚糖片段适用于潜在的治疗开发:一份初步报告。
Front Mol Biosci. 2023 Feb 15;10:1082526. doi: 10.3389/fmolb.2023.1082526. eCollection 2023.
6
1,2-Dibenzoylhydrazine as a Multi-Inhibitor Compound: A Morphological and Docking Study.1,2-二苯甲酰肼作为一种多抑制剂化合物:形态学和对接研究。
Int J Mol Sci. 2023 Jan 11;24(2):1425. doi: 10.3390/ijms24021425.
7
Ligand Growing Experiments Suggested 4-amino and 4-ureido pyridazin-3(2)-one as Novel Scaffold for FABP4 Inhibition.配体生长实验表明4-氨基和4-脲基哒嗪-3(2)-酮是用于抑制脂肪酸结合蛋白4(FABP4)的新型骨架。
Pharmaceuticals (Basel). 2022 Oct 28;15(11):1335. doi: 10.3390/ph15111335.
8
Triazoloquinoxalines-based DNA intercalators-Topo II inhibitors: design, synthesis, docking, ADMET and anti-proliferative evaluations.基于三唑并喹喔啉的 DNA 插入剂-拓扑异构酶 II 抑制剂:设计、合成、对接、ADMET 和抗增殖评估。
J Enzyme Inhib Med Chem. 2022 Dec;37(1):1556-1567. doi: 10.1080/14756366.2022.2080205.